AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.580
-0.140 (-3.76%)
At close: Dec 26, 2025, 4:00 PM EST
3.589
+0.009 (0.26%)
After-hours: Dec 26, 2025, 7:59 PM EST
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.07 billion as of December 26, 2025. Its market cap has increased by 20.14% in one year.
Market Cap
1.07B
Enterprise Value
718.17M
1-Year Change
20.14%
Ranking
Category
Stock Price
$3.58
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.07B, a decrease of -93.16%. That is a compound annual growth rate of -41.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 1.07B | 23.83% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.00B |
| Johnson & Johnson | 500.24B |
| AbbVie | 406.46B |
| UnitedHealth Group | 300.58B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 265.03B |
| Novo Nordisk | 232.28B |